Skip to main content
. Author manuscript; available in PMC: 2018 Oct 23.
Published in final edited form as: Contemp Clin Trials. 2017 Mar 19;57:29–36. doi: 10.1016/j.cct.2017.03.006

Table 2.

Patient QOL and symptom scores at baseline by neoadjuvant treatment status.

All
Neoadjuvant = No
Neoadjuvant = Yes
N Mean SD N Mean SD N Mean SD p-Value
Physical well-being 123 19.7 5.6 93 19.3 5.7 30 20.9 5.0 0.184
Functional well-being 123 14.3 6.1 93 13.7 6.1 30 16.2 6.0 0.048
Additional concerns 123 31.6 6.6 93 30.7 6.5 30 34.2 6.4 0.012
FACT-O-TOI 123 65.6 15.6 93 63.8 15.5 30 71.3 14.7 0.020
Abdominal discomfort 123 11.1 3.7 93 10.9 3.8 30 11.6 3.4 0.376
Neurotoxicity/ 123 14.8 2.0 93 15.1 1.8 30 14.1 2.5 0.020
neuropathy (high is good)
Fatigue (high = bad) 123 19.2 8.9 93 19.6 9.1 30 18.0 8.3 0.396